Announcements Trials
Browse Landscape

Phase

Phase NA 15Phase 2 5Phase 1 4Phase 3 3Phase EARLY_PHASE1 1Phase 1/2 1

Status

Terminated 2Withdrawn 1Completed 1

Sponsor Class

INDUSTRY 6OTHER 4NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 523Leukemia, Myeloid, Acute 499Neoplasms 381Carcinoma, Non-Small-Cell Lung 381Pancreatic Neoplasms 329Precursor Cell Lymphoblastic Leukemia-Lymphoma 319Multiple Myeloma 312Glioblastoma 311Melanoma 309Prostatic Neoplasms 293Leukemia 289Neoplasm Metastasis 284Brain Neoplasms 276Lymphoma 271Lung Neoplasms 270Recurrence 266Ovarian Neoplasms 247Colorectal Neoplasms 246Lymphoma, Non-Hodgkin 242Leukemia, Lymphocytic, Chronic, B-Cell 231Myelodysplastic Syndromes 208Glioma 208Lymphoma, Large B-Cell, Diffuse 186Carcinoma, Hepatocellular 173Lymphoma, Follicular 167Head and Neck Neoplasms 162Hodgkin Disease 160Lymphoma, Mantle-Cell 155Burkitt Lymphoma 154Sarcoma 150

Interventions

advexin 1Surveys and Questionnaires 1Nivolumab 1Cholecalciferol 1Blood Specimen Collection 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Carcinoma in Situ × Clear all
NCT06263582 2025-08-19

Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya

UNC Lineberger Comprehensive Cancer Center

Phase 1 Completed
12 enrolled 18 charts
GynecologicLymphoid

Carcinoma in Situ, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Lymphoma, Follicular

NCT02698293 2022-11-22

PDT Plus Vitamin D3 for Anal Dysplasia

Abramson Cancer Center at Penn Medicine

Phase 1 Withdrawn

Carcinoma in Situ

NCT03106610 2018-05-24

Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy

M.D. Anderson Cancer Center

Phase 1 Terminated
1 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

NCT00410865 2011-12-07

Wild Type p53 Adenovirus for Oral Premalignancies

M.D. Anderson Cancer Center

Phase 1 Terminated
4 enrolled
Head & Neck

Carcinoma in Situ, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡